OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
CAI$19.1358

CAI.O

Medical Equipment, Supplies & DistributionVerified

CAI.O maintains a strong liquidity position, with cash and equivalents amounting to $796.27 million, significantly exceeding its total liabilities of $548.36 million, resulting in a current ratio of 7.85. The company's price-to-book ratio of 9.37 and a debt-to-equity ratio of 0.66 indicate a relatively conservative capital structure. Profitability metrics reveal a challenging financial position, with a net loss of $68.09 million and a negative return on equity of -11.79%. The operating income of $25.22 million is modest compared to the gross profit of $541.04 million, suggesting high operating expenses or inefficiencies in cost management. The company's geographic and segment exposure is not explicitly detailed in the available data, but the revenue concentration within the healthcare services and equipment industry implies a high dependency on this sector. This concentration could pose risks in the event of regulatory changes or market downturns in healthcare. Growth trajectory appears mixed, with a free cash flow of -$446.17 million indicating significant outflows, despite a positive operating cash flow of $83.16 million. The capital expenditure of -$16.26 million suggests a reduction in investment in physical assets, which may affect long-term growth potential. Risk factors include a low liquidity risk and a low dilution risk, with no immediate filing-based liquidity or dilution flags detected. The company's negative net income and high price-to-book ratio may also signal potential valuation overextension relative to its asset base. Recent events, including analyst estimates, show a mean price target of $30.46 and a median price target of $30.00, with a mean recommendation of 1.69, indicating a generally positive outlook from analysts. However, the company's current market price of $19.13 is below these targets, suggesting potential for upward movement.

30-day price · CAI-3.73 (-18.3%)
Low$14.19High$22.16Close$16.67As of28 May, 00:00 UTC
Profile
CompanyCAI.O
TickerCAI.O
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. CAI.O operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.

Classification. The company is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a classification confidence of 0.92.

CAI.O maintains a strong liquidity position, with cash and equivalents amounting to $796.27 million, significantly exceeding its total liabilities of $548.36 million, resulting in a current ratio of 7.85. The company's price-to-book ratio of 9.37 and a debt-to-equity ratio of 0.66 indicate a relatively conservative capital structure. Profitability metrics reveal a challenging financial position, with a net loss of $68.09 million and a negative return on equity of -11.79%. The operating income of $25.22 million is modest compared to the gross profit of $541.04 million, suggesting high operating expenses or inefficiencies in cost management. The company's geographic and segment exposure is not explicitly detailed in the available data, but the revenue concentration within the healthcare services and equipment industry implies a high dependency on this sector. This concentration could pose risks in the event of regulatory changes or market downturns in healthcare. Growth trajectory appears mixed, with a free cash flow of -$446.17 million indicating significant outflows, despite a positive operating cash flow of $83.16 million. The capital expenditure of -$16.26 million suggests a reduction in investment in physical assets, which may affect long-term growth potential. Risk factors include a low liquidity risk and a low dilution risk, with no immediate filing-based liquidity or dilution flags detected. The company's negative net income and high price-to-book ratio may also signal potential valuation overextension relative to its asset base. Recent events, including analyst estimates, show a mean price target of $30.46 and a median price target of $30.00, with a mean recommendation of 1.69, indicating a generally positive outlook from analysts. However, the company's current market price of $19.13 is below these targets, suggesting potential for upward movement.
Key takeaways
  • CAI.O has a strong liquidity position with a current ratio of 7.85 and significant cash reserves.
  • The company is experiencing a net loss and negative return on equity, indicating poor profitability.
  • Analysts have a generally positive outlook, with a mean price target of $30.46.
  • The company's capital structure is relatively conservative, with a debt-to-equity ratio of 0.66.
  • Free cash flow is negative, suggesting significant outflows and potential challenges in sustaining operations.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$812.0M
Gross profit$541.0M
Operating income$25.2M
Net income-$68.1M
R&D
SG&A
D&A
SBC
Operating cash flow$83.2M
CapEx-$16.3M
Free cash flow-$446.2M
Total assets$1.13B
Total liabilities$548.4M
Total equity$577.3M
Cash & equivalents$796.3M
Long-term debt$379.0M
Valuation
Market price$19.13
Market cap$5.41B
Enterprise value$4.99B
P/E
Reported non-GAAP P/E
EV/Revenue6.2
EV/Op income197.9
EV/OCF60.0
P/B9.4
P/Tangible book9.4
Tangible book$577.3M
Net cash$417.3M
Current ratio7.8
Debt/Equity0.7
ROA-6.0%
ROE-11.8%
Cash conversion-1.2%
CapEx/Revenue-2.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
MetricCAIActivity
Op margin3.1%3.9% medp25 -31.3% · p75 14.4%below median
Net margin-8.4%2.4% medp25 -30.5% · p75 11.1%below median
Gross margin66.6%46.7% medp25 28.2% · p75 63.1%top quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-2.0%-4.8% medp25 -11.6% · p75 -2.4%top quartile
Debt / equity66.0%17.9% medp25 2.7% · p75 52.2%top quartile
Observations
IR observations
Mean price target30.46 USD
Median price target30.00 USD
High price target38.00 USD
Low price target21.00 USD
Mean recommendation1.69 (1=strong buy, 5=strong sell)
Strong-buy count6.00
Buy count5.00
Hold count2.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.15 USD
Last actual EPS-3.22 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-06 20:12 UTC#f3c98e16
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 14:23 UTCJob: 08a73cf3